BC Platforms’ Global Data Partner Network provides patient level, longitudinal, and geographically diverse real world data (RWD) for use as external control arms (ECAs) in randomised human clinical trials.
Through the use of RWD, fewer patients are required to be directly enrolled in randomised clinical trials, enabling broader patient inclusion and shaving significant time off the clinical development process — saving cost and resource — while facilitating improved access to new drugs, in new markets, for the global patient population.
Download this factsheet to learn more about what we can offer Pharma using RWD as ECAs.
